Trial Profile
Effect of administration frequency of teneligliptin on the diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Mar 2015
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Mar 2015 Status changed from recruiting to completed, according to University Hospital Medical Information Network - Japan record.
- 21 Aug 2013 New trial record